Preradiation Chemotherapy in Primary High-Risk Brainstem Tumors: Phase II Study CCG-9941 of the Children’s Cancer Group
Mark T. Jennings(Johns Hopkins University), Violet Shen(Ruhr University Bochum), Warren A. McGuire(Children's Hospital of Orange County), Mitchel S. Berger(University of California, San Francisco), Carol S. Bruggers(University of Utah), Deborah A. Lafond(Children's Hospital of Orange County), Lawrence J. Ettinger(Saint Peter's University Hospital), Thomas Moulton(Children's Hospital of Orange County), Richard Sposto(Children's Hospital of Los Angeles), David E. Mandelbaum(Children's Hospital of Orange County), Lee McNeely(Children's Hospital of Orange County), Ian F. Pollack(Children's Hospital of Pittsburgh), L. Gilbert Vezina(Children's Hospital of Orange County), Charles R. Fitz(Children's Hospital of Orange County), Janet M. Bruner(Children's Hospital of Orange County), James M. Boyett(University of Illinois Chicago), Emi Holmes(Children's Hospital of Orange County), Ka-Wah Chan(Children's Hospital of Orange County), Kathryn E. Dusenbery(Children's Hospital of Orange County), Vicky Massey(Children's Hospital of Orange County)
Cited by 105
Related Papers
Comprehensive genomic characterization defines human glioblastoma genes and core pathways
|Nature|2008|7.8k
Update on Key Emerging Challenges in Cystic Fibrosis
|Medical Principles and Practice|2014|3.7k
Intertumoral Heterogeneity within Medulloblastoma Subgroups
|Cancer Cell|2017|1.3k
The genetic landscape of high-risk neuroblastoma
|Nature Genetics|2013|1.2k
Impact of Intraoperative Stimulation Brain Mapping on Glioma Surgery Outcome: A Meta-Analysis
|Journal of Clinical Oncology|2012|1k